Quality & compliance

Quality & complianceOfficial

Class II drug recall: Lubricant Eye Drops-Cameron Pharmaceuticals (Sterling Pharmaceutical Services Llc)

Lack of Assurance of Sterility Recall D-0862-2026; status Ongoing; distribution: USA Nationwide.

🇺🇸 FDA enforcement report · Wed 30 Sep 2026

Quality & complianceOfficial

Class II drug recall: AvKare Carboxymethylcellulose Sodium Ophthalmic Solution 0.5% (Sterling Pharmaceutical Services Llc)

Lack of Assurance of Sterility Recall D-0855-2026; status Ongoing; distribution: USA Nationwide.

🇺🇸 FDA enforcement report · Wed 30 Sep 2026

Quality & complianceOfficial

Class II drug recall: TRP The Relief Products* Gentle Eyes Lubricant Eye Drops (Sterling Pharmaceutical Services Llc)

Lack of Assurance of Sterility Recall D-0860-2026; status Ongoing; distribution: USA Nationwide.

🇺🇸 FDA enforcement report · Wed 30 Sep 2026

Quality & complianceOfficial

Class II drug recall: Dopamine HCl Inj. (Pfizer)

Lack of Assurance of Sterility Recall D-0853-2026; status Ongoing; distribution: US Nationwide..

🇺🇸 FDA enforcement report · Wed 23 Sep 2026

Quality & complianceOfficial

Class II drug recall: Chlorthalidone Tablets (Inventia Healthcare Limited)

Failed Dissolution Specifications Recall D-0852-2026; status Ongoing; distribution: U.S. Nationwide.

🇺🇸 FDA enforcement report · Wed 23 Sep 2026

Quality & complianceOfficial

Class II drug recall: Lidocaine Ointment USP (Sun Pharma /Taro)

Failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH). Recall D-0848-2026; status Ongoing; distribution: Nationwide in the USA.

🇺🇸 FDA enforcement report · Wed 23 Sep 2026

Quality & complianceOfficial

Class II drug recall: Fluphenazine HCl Elixir (Safecor Health, Llc)

Failed Stability Specifications Recall D-0841-2026; status Ongoing; distribution: Nationwide in the USA..

🇺🇸 FDA enforcement report · Wed 23 Sep 2026

Quality & complianceOfficial

Class I drug recall: Thyroid Tablets (Vitruvias Therapeutics Inc)

Superpotent Drug Recall D-0866-2026; status Ongoing; distribution: US Nationwide..

🇺🇸 FDA enforcement report · Wed 23 Sep 2026

Quality & complianceOfficial

Class I drug recall: 0.9% Sodium Chloride Injection (B Braun Medical Inc)

Presence of Particulate Matter: particulate matter identified as iron oxide, inorganic material, cellulose cotton fiber or polystyrene Recall D-0869-2026; status Ongoing; distribution: Nationwide within the United States.

🇺🇸 FDA enforcement report · Wed 16 Sep 2026

Quality & complianceOfficial

Class I drug recall: Dextrose Injection (Baxter Healthcare Corporation)

Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution. Recall D-0850-2026; status Ongoing; distribution: U.S. Nationwide..

🇺🇸 FDA enforcement report · Wed 16 Sep 2026

Quality & complianceOfficial

Class I drug recall: Epinephrine Injection (American Regent, Inc.)

Presence of Particulate Matter and Lack of Assurance of Sterility. Particulate matter identified as nylon, cellulosic, acrylic, polyethylene and glass and broken and leaking vials. Recall D-0865-2026; status Ongoing; distribution: Nationwide within the U.S.A.

🇺🇸 FDA enforcement report · Wed 16 Sep 2026

Quality & complianceOfficial

Class II drug recall: fentaNYL Citrate (Ourpharma Llc)

Labeling: Not Elsewhere Classified: Complaint received on 08/31/2026 regarding the discrepancy of the IV bag expiry (07/31/2026 and 11/30/2026) and the product expiry (12/09/2026). Recall D-0864-2026; status Ongoing; distribution: Nationwide within the U.S.

🇺🇸 FDA enforcement report · Wed 16 Sep 2026

← Newer

Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.